Physician profile
David G Cunningham
NPI 1841229424
$9,299.24
in general payments reported to CMS, 2019-2025
15 companies · $98.04 in 2025
The $98.04 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,197 · 2020: $189 · 2021: $309 · 2022: $12.14 · 2023: $494 · 2025: $98.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $7,531.09 | 2019-2020 | |
| Abbott Laboratories | $880.80 | 2019-2025 | Aveir |
| Pfizer INC. | $206.12 | 2019-2023 | |
| Actelion Pharmaceuticals US, INC. | $166.95 | 2019 | |
| Novartis Pharmaceuticals Corporation | $115.44 | 2019 | |
| Atricure, INC. | $106.52 | 2021 | |
| E.R. Squibb & Sons, L.L.C. | $83.98 | 2019-2023 | Camzyos |
| Regeneron Healthcare Solutions, INC. | $49.63 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $34.28 | 2019 | |
| Amgen INC. | $34.21 | 2019 | |
| Sanofi-Aventis U.S. LLC | $21.62 | 2019 | |
| Allergan, INC. | $20.99 | 2019 | |
| Irhythm Technologies, INC. | $16.55 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $15.89 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $15.17 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cunningham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.